Look for:

Our offer for

ABBVIE INC.


ISIN:
US00287Y1091
WKN:
00287Y109

2024/05/24 22:00:02
Price
157.06 USD
Difference -0.76% (-1.20)

General attributes

ISINUS00287Y1091
SymbolABBV
ExchangeNYSE
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)256,523 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)156.00 USD (100)
Ask (Ask size)158.55 USD (100)
Open158.36 USD
High158.78 USD
Low156.36 USD
Close (prev. day)158.26 USD
VWAP157.141821 USD
Volume (pcs)3,691,730
Trading volume580,109,070.46
Number of trades62,356
Last size-

Futures and Options

Related Futures15
Related Options-

PDF Downloads

Company report: ABBVIE INC.PDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2024/05/24 22:00:02
Price
157.06 USD
Difference -0.76% (-1.20)

General attributes

ISINUS00287Y1091
SymbolABBV
ExchangeNYSE
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)256,523 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)156.00 USD (100)
Ask (Ask size)158.55 USD (100)
Open158.36 USD
High158.78 USD
Low156.36 USD
Close (prev. day)158.26 USD
VWAP157.141821 USD
Volume (pcs)3,691,730
Trading volume580,109,070.46
Number of trades62,356
Last size-

Performance and Risk

6m1Y3Y
Perf (%)+14.10%+10.19%+51.70%
Perf (abs.)+17.88+13.38+49.31
Beta0.440.300.34
Volatility19.9120.6122.82
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)160.48 USD (4,594,695)
Ø price 30 days | Ø volume 30 days (pcs.)162.96 USD (5,113,735)
Ø price 100 days | Ø volume 100 days (pcs.)169.57 USD (5,485,816)
Ø price 250 days | Ø volume 250 days (pcs.)154.73 USD (5,356,988)
YTD High | date182.89 USD (2024/03/12)
YTD Low | date154.77 USD (2024/01/02)
52 Weeks High | date182.89 USD (2024/03/12)
52 Weeks Low | date130.96 USD (2023/06/28)

All listings for ABBVIE INC.

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Berlin2024/05/2420:21144.46 EUR0.0017
Duesseldorf2024/05/2419:30144.42 EUR0.006
Euronext Milan MTF Global Equity Market2024/05/2417:44145.42 EUR0.001
Euronext Milan MTF Trading After Hours2024/03/2119:49162.60 EUR0.012
Frankfurt2024/05/2416:31144.98 EUR0.024
London Stock Exchange European Trade Reporting2024/05/2417:30158.01 USD0.008
Munich2024/05/2408:09146.68 EUR0.002
NYSE2024/05/2422:00157.06 USD580.1162,356
Stuttgart2024/05/2419:38144.42 EUR0.0510
Tradegate2024/05/2422:26144.78 EUR0.3880
Vienna Stock Exchange2024/05/2417:32145.14 EUR0.002
Xetra2024/05/2417:35145.16 EUR0.0921

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=138490&ID_TYPE_IMAGE_LOGO=2

Contact Details

ABBVIE INC.
- -
1 North Waukegan Road - 60064-6400 North Chicago
Telefon: +1-847-932-7900
Fax: +
E-mail: -

PDF Downloads

Company report: ABBVIE INC.PDF Download

Company Profile

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

Members of Management Board

Robert AlpernMember of Board of Directors
Susan QuagginMember of Board of Directors
Brett HartMember of Board of Directors
Edward RappMember of Board of Directors
Frederick WaddellMember of Board of Directors
Glenn TiltonMember of Board of Directors
Jennifer DavisMember of Board of Directors
Melody MeyerMember of Board of Directors
Rebecca RobertsMember of Board of Directors
Roxanne AustinMember of Board of Directors
Thomas FreymanMember of Board of Directors
William BurnsideMember of Board of Directors
Richard A. GonzalezChairman of Managing Board
Azita Saleki-GerhardtMember of Executive Committee
Jeffrey R. StewartMember of Executive Committee
Nicholas DonoghoeMember of Executive Committee
Perry C. SiatisMember of Executive Committee
Robert A. MichaelMember of Executive Committee
Scott ReentsMember of Executive Committee
Timothy J. RichmondMember of Executive Committee






Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer